Detection of early gastric cancer using hydro-stomach CT

March 15, 2011, World Journal of Gastroenterology

A research team from South Korea evaluated the difference in diagnostic performance of hydro-stomach computed tomography (CT) to detect early gastric cancer (EGC) between blinded and nonblinded analysis and to assess independent factors affecting visibility of cancer foci. They found that the diagnostic performance of hydrostomach CT to detect an EGC was not significantly different between blinded and nonblinded analysis. The tumor size and invasion depth were independent factors for visibility.

Traditionally, both air and tap water have been used as oral to achieve adequate gastric distension for preoperative computed tomography (CT) imaging in patients with early (EGC). Despite introduction of multi-detector row CT techniques and the use of multiplanar reconstruction (MPR) images, the detection rate of EGC on hydrostomach CT has still been unsatisfactory.

A research article published on February 28, 2011 in the addresses this question. The authors conducted a comparison study for the detection of EGC on hydro-stomach CT between blinded analysis and unblinded analysis with regard to gastroscopic and surgical-histological findings to see whether the detection rate of EGC on unblinded analysis can be improved as compared to that of blinded analysis. The researchers further aimed to assess factors affecting visibility of cancer foci on hydro-stomach CT imaging.

The study showed that hydro-stomach was not a reliable tool for the detection of EGC. The poor diagnostic performance of hydro-stomach CT to detect EGC was not significantly different between blinded and unblinded analysis. The size and depth of invasion of an EGC were two independent factors for visibility.

More information: Park KJ, Lee MW, Koo JH, Park Y, Kim H, Choi D, Lee SJ. Detection of early gastric cancer using hydro-stomach CT: Blinded vs unblinded analysis. World J Gastroenterol 2011; 17(8): 1051-1057. www.wjgnet.com/1007-9327/full/v17/i8/1051.htm

Related Stories

Recommended for you

Stem cell vaccine immunizes lab mice against multiple cancers

February 15, 2018
Stanford University researchers report that injecting mice with inactivated induced pluripotent stem cells (iPSCs) launched a strong immune response against breast, lung, and skin cancers. The vaccine also prevented relapses ...

Induced pluripotent stem cells could serve as cancer vaccine, researchers say

February 15, 2018
Induced pluripotent stem cells, or iPS cells, are a keystone of regenerative medicine. Outside the body, they can be coaxed to become many different types of cells and tissues that can help repair damage due to trauma or ...

Team paves the way to the use of immunotherapy to treat aggressive colon tumors

February 15, 2018
In a short space of time, immunotherapy against cancer cells has become a powerful approach to treat cancers such as melanoma and lung cancer. However, to date, most colon tumours appeared to be unresponsive to this kind ...

Can our genes help predict how women respond to ovarian cancer treatment?

February 15, 2018
Research has identified gene variants that play a significant role in how women with ovarian cancer process chemotherapy.

First comparison of common breast cancer tests finds varied accuracy of predictions

February 15, 2018
Commercially-available prognostic breast cancer tests show significant variation in their abilities to predict disease recurrence, according to a study led by Queen Mary University of London of nearly 800 postmenopausal women.

Catching up to brain cancer: Researchers develop accurate model of how aggressive cancer cells move and spread

February 15, 2018
A brief chat at a Faculty Senate meeting put two University of Delaware researchers onto an idea that could be of great value to cancer researchers.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.